Effects of Dry Needling in Teres Major in Patients With Shoulder Pain

March 1, 2021 updated by: Luis Ceballos Laita, Universidad de Zaragoza
The aim of the study is to investigate the effects of the dry needling technique in teres major muscles on pain, range of motion, strength and extensibility of the posterior part of the tissues of the shoulder in athletes with shoulder pain.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Athletes with Shoulder pain
  • Glenohumeral internal rotation deficit
  • Presence of active MTrP in the teres major muscle

Exclusion Criteria:

  • Previous surgery in the upper limb
  • Previous physiotherapy treatments in the shoulder
  • Dry needling contraindications
  • Previous dry needling experience to mantain the blinding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Control
EXPERIMENTAL: DN
Other: Dry needling
Dry needling based on fast-in fast-out technique in the teresa major muscle

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity
Time Frame: Baseline
the examiners assess the pain intensity using a visual analoigue scale
Baseline
Pain intensity
Time Frame: immediately after the intervention
the examiners assess the pain intensity using a visual analoigue scale
immediately after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of motion
Time Frame: Baseline
the examiners assess the shoulder range of motion with an universal goniometer
Baseline
Extensibility
Time Frame: Baseline
the examiners assess the extensibility of the posterior part of the tissues of the shoulder using a digital inclinometer
Baseline
Range of motion
Time Frame: immediately after the intervention
the examiners assess the shoulder range of motion with an universal goniometer
immediately after the intervention
Strength
Time Frame: Baseline
the examiners assess the shoulder range of motion with a hand-held dynamometer
Baseline
Strength
Time Frame: immediately after the intervention
the examiners assess the shoulder range of motion with a hand-held dynamometer
immediately after the intervention
Extensibility
Time Frame: immediately after the intervention
the examiners assess the extensibility of the posterior part of the tissues of the shoulder using a digital inclinometer
immediately after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad de Zaragoza

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 25, 2021

Primary Completion (ANTICIPATED)

December 20, 2021

Study Completion (ANTICIPATED)

January 5, 2022

Study Registration Dates

First Submitted

February 25, 2021

First Submitted That Met QC Criteria

March 1, 2021

First Posted (ACTUAL)

March 2, 2021

Study Record Updates

Last Update Posted (ACTUAL)

March 2, 2021

Last Update Submitted That Met QC Criteria

March 1, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CASVE-NM-21-504

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shoulder Pain

Clinical Trials on Dry needling

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe